Utility of PSMA PET-CT in Prostate Malignancies

This course is designed for consultants who already have experience reporting FDG PET-CT scans and who wish to explore the role of PSMA PET-CT reporting as it relates to the imaging workup of patients with prostate cancer, and the role of PSMA imaging in Lutetium PSMA theranostics.

This course comprises four tutorials in total; three that provide an overview of PSMA PET-CT reporting as it relates to the imaging workup of patients with prostate cancer and a fourth tutorial that describes the role of PSMA imaging in Lutetium PSMA theranostics.

It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorials.

Suitable for radiologists and nuclear medicine physicians who intend to train to report PSMA PET-CT, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT (Multi-Disciplinary Team).

Learning Outcomes

• Define PSMA PET-CT reporting as it relates to the imaging workup of patients with prostate cancer
• Describe the role of PSMA imaging in Lutetium PSMA theranostics
• Explain how establishing a systematic routine for reviewing scans helps reduce errors where there is obvious local disease recurrence.
• Differentiate between ranges of appearance of pathological uptake at the primary tumour uptake site and how these are influenced by various treatments and tumour types.
• Recognise typical patterns of nodal dissemination of prostate cancer and understand their relevance to management options
• Describe the limitations of PET-CT with regards sensitivity for small lesions and false negative assessment
• Develop skills in discriminating subtle metastatic nodal uptake from reactive or physiological uptake
• Develop an approach for dealing with uncertainty surrounding equivocal findings
• Interpret the range of appearances of bone metastases on PSMA PET-CT
• Apply knowledge of the principles of non-specific bone lesions (NSBLs) to guide assessment of genuine metastatic disease to the skeleton
• Recognise non-nodal soft tissue metastases encountered during PET-CT reporting

Please note: To mark this course as complete on your Learning Dashboard and access your certificate of completion, you must finish all learning modules and submit the course evaluation.